152 related articles for article (PubMed ID: 6714806)
1. Carcinosarcoma of the uterus: a 40-year experience from the state of Missouri.
Doss LL; Llorens AS; Henriquez EM
Gynecol Oncol; 1984 May; 18(1):43-53. PubMed ID: 6714806
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population.
Le T
Eur J Surg Oncol; 2001 Apr; 27(3):282-5. PubMed ID: 11373106
[TBL] [Abstract][Full Text] [Related]
3. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study.
Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K
Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812
[TBL] [Abstract][Full Text] [Related]
4. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
5. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.
Leath CA; Numnum TM; Kendrick JE; Frederick PJ; Rocconi RP; Conner MG; Straughn JM
Int J Gynecol Cancer; 2009 Jul; 19(5):888-91. PubMed ID: 19574779
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study.
Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL
Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850
[TBL] [Abstract][Full Text] [Related]
7. Vaginal brachytherapy for early-stage carcinosarcoma of the uterus.
Brown LC; Petersen IA; Haddock MG; Bakkum-Gamez JN; Lee LJ; Cimbak NC; Berkowitz RS; Viswanathan AN
Brachytherapy; 2015; 14(4):433-9. PubMed ID: 25890795
[TBL] [Abstract][Full Text] [Related]
8. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus.
Yamada SD; Burger RA; Brewster WR; Anton D; Kohler MF; Monk BJ
Cancer; 2000 Jun; 88(12):2782-6. PubMed ID: 10870061
[TBL] [Abstract][Full Text] [Related]
9. Prognostic determinants in patients with uterine and ovarian carcinosarcoma.
Rauh-Hain JA; Shoni M; Schorge JO; Goodman A; Horowitz NS; del Carmen MG
J Reprod Med; 2013; 58(7-8):297-304. PubMed ID: 23947079
[TBL] [Abstract][Full Text] [Related]
10. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
11. Pathologic prognostic factors in stage I-III uterine carcinosarcoma treated with postoperative radiotherapy.
Rovirosa A; Ascaso C; Arenas M; Ríos I; Del Pino M; Ordi J; Morales J; Gascón M; Pahisa J; Biete A
Arch Gynecol Obstet; 2014 Aug; 290(2):329-34. PubMed ID: 24633893
[TBL] [Abstract][Full Text] [Related]
12. Carcinosarcoma of the uterus. Report of a case surviving eleven years.
Falk VS
Wis Med J; 1973 Feb; 72(2):85-8. PubMed ID: 4688535
[No Abstract] [Full Text] [Related]
13. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas.
Sorbe B; Johansson B
Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339
[TBL] [Abstract][Full Text] [Related]
14. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study.
Sartori E; Bazzurini L; Gadducci A; Landoni F; Lissoni A; Maggino T; Zola P; La Face B
Gynecol Oncol; 1997 Oct; 67(1):70-5. PubMed ID: 9345359
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
Int J Clin Oncol; 2016 Feb; 21(1):168-76. PubMed ID: 26084780
[TBL] [Abstract][Full Text] [Related]
16. Presentation and management of carcinosarcoma of the uterus.
Vaccarello L; Curtin JP
Oncology (Williston Park); 1992 May; 6(5):45-9; discussion 53-4, 59. PubMed ID: 1534676
[TBL] [Abstract][Full Text] [Related]
17. Prognostic features of surgical stage I uterine carcinosarcoma.
Ferguson SE; Tornos C; Hummer A; Barakat RR; Soslow RA
Am J Surg Pathol; 2007 Nov; 31(11):1653-61. PubMed ID: 18059221
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Chemotherapy Response With Platinum and Taxane in the Advanced Stage of Ovarian and Uterine Carcinosarcoma: A Clinical Implication of In vitro Drug Resistance Assay.
Matsuo K; Bond VK; Im DD; Rosenshein NB
Am J Clin Oncol; 2010 Aug; 33(4):358-63. PubMed ID: 19875949
[TBL] [Abstract][Full Text] [Related]
19. FIGO staging for carcinosarcoma: can the revised staging system predict overall survival?
Pradhan TS; Stevens EE; Ablavsky M; Salame G; Lee YC; Abulafia O
Gynecol Oncol; 2011 Nov; 123(2):221-4. PubMed ID: 21889193
[TBL] [Abstract][Full Text] [Related]
20. Uterine Inversion as a Result of a Large Prolapsed Carcinosarcoma of the Uterus.
Kean SL; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1181-1184. PubMed ID: 30686610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
